Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmune hepatitis in the elderly.

C Schramm1, S Kanzler, K H zum Büschenfelde

  • 1I. Department of Medicine, Johannes Gutenberg-University, Mainz, Germany.

The American Journal of Gastroenterology
|May 26, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primary sclerosing cholangitis: Time to rethink imaging criteria for early disease detection.

Journal of hepatology·2026
Same author

Trends in Primary Biliary Cholangitis: Prospective Cohort Study From the European Reference Network Registry (R-LIVER).

United European gastroenterology journal·2025
Same author

Health-related quality of life analysis of the LEAP-002 study of lenvatinib plus pembrolizumab versus lenvatinib as first-line treatment for advanced hepatocellular carcinoma.

ESMO open·2025
Same author

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

High vaccination coverage and infection rate result in a robust SARS-CoV-2-specific immunity in the majority of liver cirrhosis and transplant patients: A single-center cross-sectional study.

United European gastroenterology journal·2024
Same author

What contribution can genetics make to predict the risk of Alzheimer's disease?

Revue neurologique·2022

Autoimmune hepatitis (AIH) is often diagnosed late in older adults, presenting similarly to younger patients. Early consideration of AIH in the elderly is crucial for timely immunosuppressive therapy and excellent prognosis.

Area of Science:

  • Hepatology
  • Immunology
  • Geriatrics

Background:

  • Autoimmune hepatitis (AIH) is typically considered a disease affecting young women and those in menopause.
  • Limited data exists on the prevalence and clinical presentation of AIH in individuals aged 65 years and older.

Purpose of the Study:

  • To determine the frequency and clinical characteristics of autoimmune hepatitis in patients aged 65 years or older.
  • To compare the diagnostic delay, presentation, and outcomes of older AIH patients with younger counterparts.

Main Methods:

  • Retrospective chart review of 120 consecutive autoimmune hepatitis outpatients.
  • Identification of 20 patients diagnosed at age 65 or older and comparison with 20 younger patients.
  • Analysis of diagnostic timelines, clinical presentation, human leukocyte antigen (HLA) types, and treatment responses.

Related Experiment Videos

Main Results:

  • 17% of AIH patients were diagnosed at age 65 or older.
  • Older patients experienced significantly longer diagnostic delays (median 8.5 vs. 3.5 months).
  • Presentation with acute icteric hepatitis was common in both age groups; HLA-A1-B8 was less frequent in older patients.

Conclusions:

  • Delayed diagnosis of AIH in the elderly is likely due to under-recognition of the disease in this demographic.
  • Clinical presentation and remission rates are similar to younger patients, suggesting menopause does not significantly alter AIH course.
  • HLA type may influence AIH onset age; early consideration of AIH in older adults is vital for prompt treatment initiation and favorable outcomes.